Evidence map›Paper›PMID 14742559›Full record

ArticleInfection and immunity2004

Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains.

James G Fox, Arlin B Rogers, Mark T Whary, Zhongming Ge, Nancy S Taylor, Sandy Xu, Bruce H Horwitz, Susan E Erdman

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 183 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Revisiting bacterial cytolethal distending toxin structure and function.Frontiers in cellular and infection microbiology · 2023
    Article
  5. Review
  6. Review
  7. Occurrence and Characteristics ofMicroorganisms · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Campylobacter Virulence Factors and Molecular Host-Pathogen Interactions.Current topics in microbiology and immunology · 2021
    Review
  13. Frontiers in cellular and infection microbiology · 2021
    Article
  14. Gut Microbiota and Colon Cancer: A Role for Bacterial Protein Toxins?International journal of molecular sciences · 2020
    Review
  15. Functional Study ofToxins · 2020
    Article
  16. Draft Genome Sequences of NovelMicrobiology resource announcements · 2020
    Article
  17. Virulence Traits of InpatientMicroorganisms · 2020
    Article
  18. Review
  19. Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.Progress in molecular biology and translational science · 2020
    Review
  20. Article

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

James G FoxDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA. jgfox@mit.edu
Arlin B Rogers
Mark T Whary
Zhongming Ge
Nancy S Taylor
Sandy Xu
Bruce H Horwitz
Susan E Erdman
Massachusetts Institute of Technology · USBrigham and Women's Hospital · US

Funding

HELIOBACTER INDUCED HEPATITIS AND TUMORIGENESISR01CA067529 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 1995 to 2009
$3.2M
Microecology-murine gut-initiation &progression of IBDR01AI050952 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 2002 to 2005
$1.3M
NCI NIH HHS R01 CA067529NCI NIH HHS R01 CA67529NIAID NIH HHS R01 AI050952NIAID NIH HHS R01 AI50952
6 · The paper itself

Abstract

Campylobacter jejuni continues to be a leading cause of bacterial enteritis in humans. However, because there are no readily available animal models to study the pathogenesis of C. jejuni-related diseases, the significance of potential virulence factors, such as cytolethal distending toxin (CDT), in vivo are poorly understood. Mice deficient in NF-kappaB subunits (p50(-/-) p65(+/-)) in a C57BL/129 background are particularly susceptible to colitis induced by another enterohepatic microaerobe, Helicobacter hepaticus, which, like C. jejuni, produces CDT. Wild-type C. jejuni 81-176 and an isogenic mutant lacking CDT activity (cdtB mutant) were inoculated into NF-kappaB-deficient (3X) and C57BL/129 mice. Wild-type C. jejuni colonized 29 and 50% of the C57BL/129 mice at 2 and 4 months postinfection (p.i.), respectively, whereas the C. jejuni cdtB mutant colonized 50% of the C57BL/129 mice at 2 p.i. but none of the mice at 4 months p.i. Although the C57BL/129 mice developed mild gastritis and typhlocolitis, they had robust immunoglobulin G (IgG) and Th1-promoted IgG2a humoral responses to both the wild-type strain and the C. jejuni cdtB mutant. In contrast, 75 to 100% of the 3X mice were colonized with both the wild type and the C. jejuni cdtB mutant at similar levels at all times examined. Wild-type C. jejuni caused moderately severe gastritis and proximal duodenitis in 3X mice that were more severe than the gastrointestinal lesions caused by the C. jejuni cdtB mutant. Persistent colonization of NF-kappaB-deficient mice with the wild type and the C. jejuni cdtB mutant was associated with significantly impaired IgG and IgG2a humoral responses (P < 0.001), which is consistent with an innate or adaptive immune system defect(s). These results suggest that the mechanism of clearance of C. jejuni is NF-kappaB dependent and that CDT may have proinflammatory activity in vivo, as well as a potential role in the ability of C. jejuni to escape immune surveillance. NF-kappaB-deficient mice should be a useful model to further study the role of CDT and other aspects of C. jejuni pathogenesis.

Indexed as

AnimalsAntibodies, BacterialBacterial ToxinsCampylobacter InfectionsCampylobacter jejuniFemaleGastroenteritisImmunoglobulin GMaleMiceMice, Inbred C57BLNF-kappa BAntibodies, BacterialBacterial Toxinscytolethal distending toxinImmunoglobulin GNF-kappa B

Identifiers

PMID14742559
PMCPMC321575
OpenAlexW2168172793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.